ZYBERNO
Stock Report
Updated Aug 21, 2026

Insight Molecular Diagnostics Inc. (IMDX)

Healthcare • NASDAQ

$4.42

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
17.0/100
POOR BUSINESS
Insight Molecular Diagnostics Inc. (IMDX) scores 17/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-4,794.9%)
Return on Capital (Capital Efficiency):CRITICAL (-322.8%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Insight Molecular Diagnostics Inc. (IMDX) stock report — Zyberno Score 17/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, IMDX generated -$26.07M in Owner Earnings. Capital was deployed as follows: $3.49M invested in capital expenditures. Reinvestment rate: -2.6%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:4.42
Market Cap:$162.44M

Valuation Multiples (2)

P/S Ratio:154.85x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$147.42M

Price Action & Momentum (3)

Momentum Percentile:91 / 100
% of 52-Week High:51.9%
B. Profitability Assessment

Return Metrics (4)

ROA:-141.5%
Reinvestment Rate:-2.6%
Fundamental Growth Rate (g):8.5%

Margin Analysis (3)

Operating Margin Ttm:-4,794.9%
Net Margin Ttm:-4,705.3%
Ebitda Margin:-4,562.0%

TTM Performance (3)

Gross Margin Ttm:75.8%
Operating Margin Ttm:-4,794.9%
Net Margin Ttm:-4,705.3%

Yield Metrics (2)

Earnings Yield:-$40.97
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-89.8%
Latest Earnings Filed:2026-08-10

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-40.7%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:2.00x
Quick Ratio:1.98x
Cash Ratio:1.73x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:10,257,000.00
Cash And Cash Equivalents:17,756,000.00
Long Term Debt:$766.00K
Net Debt:-$15.01M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.05M
Linear Growth: -40.7%
📊 Click to view full IMDX Revenue analysis & methodology →
Cost Of Revenue Ttm:$875.00K

Profitability Breakdown (2)

Gross profit TTM: $795.00K
Linear Growth: 19.4%
📊 Click to view full IMDX Gross Profit analysis & methodology →
-$50.30M

Bottom Line Performance (3)

-$49.36M
Income Before Tax:-$60.66M
Ebitda Ttm:-47,855,000.00

Operating Expenses (5)

Operating Expenses:51,093,000.00
R And D Expense:19,134,000.00
Sga Expense:10,735,000.00
Income Tax Expense:$0.00
Interest Expense:-98,000.00

Expense Ratios (3)

R And D To Revenue Percentage:8,005.9%
Sga To Revenue Percentage:4,491.6%
Ebitda Margin:-4,562.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$29.44M
Current Assets:$20.54M
Ppe Net:6,004,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:50,742,000.00
Current Liabilities:10,286,000.00
Long Term Debt:$766.00K
Short Term Debt:$1.98M

Equity & Capital (3)

Equity:-$21.30M
Retained Earnings:-$416.31M
Common Stock:394,945,000.00

Working Capital Items (3)

Accounts Receivable:192,000.00
Inventory:207,000.00
Accounts Payable:1,871,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:661,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$23.97M-$27.46M

Investment Activities (2)

Investing Cash Flow:-$613.00K
Capital Expenditures Ttm:3,491,000.00

Financing Activities (3)

Financing Cash Flow:$24.70M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:26,024,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:2,443,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1.52
-$1.52
Earnings Per Share Ttm:-$1.34

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.03
Operating Cash Flow Per Share:-$0.60

Book Value & Capital (2)

Book Value Per Share:-$0.58
Cash Per Share:0.48

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.03x
Working Capital Turnover Ttm:0.10x

Receivables Management (2)

Receivables Turnover Ttm:5.46x
Days Sales Outstanding Ttm:66.81

Inventory Management (2)

Inventory Turnover Ttm:4.23x
Days Inventory Outstanding Ttm:86.35

Payables & Cash Cycle (2)

Days Payable Outstanding:780.47
Cash Conversion Cycle:-627.32
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:60.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$26.07M

Damodaran Growth Analysis (2)

Reinvestment Rate:-2.6%
Fundamental Growth Rate (g):8.5%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-40.7%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):19.4%
Book Value Growth Rate (Linear):-50.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:IMDX
Company Name:Insight Molecular Diagnostics Inc.
Sector:Healthcare
Industry:Medical Diagnostics
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:36.75M
Shares Outstanding Basic:36.75M
Shares Outstanding Diluted:36.75M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-21 17:17:02 UTC
Data Timestamp:2026-08-18T23:31:06.500591
Scroll to Top